medisourceasia.com

Industry News


Home

About 
medisourceasia

Magazine
Industry News
Global Trends
Events Calendar
Web Links

Web Gallery

Advertising  Info

Contact

 

Planning Commission Calls For Amendment To D&C Act To Monitor Medical Devices Sector Setter

The Planning Commission has suggested the amendment of the Drugs and Cosmetics (D&C) Act to include medical devices incorporating provisions for their risk based classification, clinical trials, conformity assessments and penalties.

The recommendation has been included in the draft plan document for the current 12th Five Year Plan, which will be approved shortly. “As recommended by the Mashelkar Committee, a Central Drug Authority needs to be set up. This authority would review the issuance of licences for manufacture and sale of drugs. Once this Authority is in place, suitable strengthening of its infrastructure and laboratories would be done. The Government would mandate that labels on drugs and food fully disclose all its ingredients,” the document said.

The Plan panel also recommended strengthening of existing, and creation of new drug testing laboratories to ensure the quality of drugs being produced in India, whether they are used for domestic distribution or for export to other countries.

“Institutional frameworks for regulation of clinical research and trials to ensure safety of research subjects will be a priority. In addition, efficient assessment and approval of new technologies, drugs and devices would also be done. The process of approval and introduction of new medical technologies, and devices, would be notified. India still has to safeguard itself from TRIPS plus provisions which will evergreen patents for more than 20 years. Safeguards like compulsory licensing, parallel imports, and so on, need to be adopted to protect national’s public health,” the panel said.

(Ref.: http://pharmabiz.com/NewsDetails.aspx?aid=72881&sid=1 )


Plastindia To Strengthen Ties With Pharma Sector To Enhance Plastics' Use

PLASTINDIA Foundation, an apex body of major associations connected with plastics including government organisations, expressed interest in exploring better business opportunities with the pharma industry for the use of plastics in the packaging of pharma products.

The size of the plastic industry today is about Rs. l,25,000 crore, of which the share of pharma industry is hardly seven percent, which is very minuscule representation considering the huge size of the industry and the potential it holds. Especially since plastics differ from metallic materials in many ways, with their durability and re-usability that can be used to manufacture containers not only for solid dosages but also for blood and injections as well as for liquids that are to be administered parenterally.

Plastindia Foundation further stressed that they are looking forward for greater opportunities that will help in developing a symbiotic relation between both the  sectors. And stated that the industry is open to provide extensive range of custom made services to support the use of plastics, within the pharma and medical device industries.

Just recently, to create a pool of skilled technicians and engineers who can think globally and implement expertise on the work floor that would be beneficial to the industry and economy at large, the foundation had initiated a major project to set up an internationally recognised university in Gujarat in collaboration with the University of Massachusetts Lowell (UMASS). The plastindia International University (PIU) will be the first institution in India that will impart information on polymer technology from concept to commercialisation.

(Ref : The CHRONICLE PHARMABIZ December 13, 2012 P.g. No. 02)

Other News

Pharmexcil To Represent India Pavilion At Arab Health 2013 In Dubai
Pharmaceuticals Export Promotion Council Of India

Archives

Advertisement

 

 


Back | Back To Top | Previous | Next